Proof of concept study to demonstrate the relationship between Improved stability of lipiodol–drug (Idarubicin) emulsion and pharmacokinetic profile for transarterial chemoembolisation of hepatocellular carcinoma.
Phase of Trial: Phase II
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Ethiodized oil (Primary) ; Idarubicin (Primary)
- Indications Liver cancer
- Focus Pharmacokinetics; Proof of concept
- 27 Oct 2016 New trial record